Revolutionizing in vivo therapy with CRISPR/Cas genome editing: breakthroughs, opportunities and challenges
Genome editing using the CRISPR/Cas system has revolutionized the field of genetic engineering, offering unprecedented opportunities for therapeutic applications in vivo. Despite the numerous ongoing clinical trials focusing on ex vivo genome editing, recent studies emphasize the therapeutic promise...
Main Authors: | Arturo Macarrón Palacios, Patrick Korus, Bodo G. C. Wilkens, Najmeh Heshmatpour, Sarita R. Patnaik |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-02-01
|
Series: | Frontiers in Genome Editing |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgeed.2024.1342193/full |
Similar Items
-
Targeting DLBCL by mutation-specific disruption of cancer-driving oncogenes
by: Najmeh Heshmatpour, et al.
Published: (2024-10-01) -
CRISPR/Cas9 Genome Editing for Tissue‐Specific In Vivo Targeting: Nanomaterials and Translational Perspective
by: Deepak Kumar Sahel, et al.
Published: (2023-07-01) -
Revolutionizing male fertility factor research in mice by using the genome editing tool CRISPR/Cas9
by: Ferheen Abbasi, et al.
Published: (2018-01-01) -
New advances in CRISPR/Cas-mediated precise gene-editing techniques
by: Chris Richardson, et al.
Published: (2023-02-01) -
CRISPR-Cas9 Gene Editing for Fruit and Vegetable Crops: Strategies and Prospects
by: Lili Wan, et al.
Published: (2021-07-01)